Handelsavisen
prelaunch
Companies Healthcare DETEC.HE
DE
DETEC.HE Nasdaq Helsinki Advanced Medical Equipment & Technology

Detection Technology Oyj

€8,66
Open in Charts → Attach watcher ⌖
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,36 %
Op margin
8,0 %
ROE
8,2 %
Net margin
6,4 %
Debt / equity
0,06
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Detection Technology Oyj develops and sells advanced medical equipment and technology, primarily focused on diagnostic and monitoring solutions for healthcare providers.

Business. Detection Technology Oyj (DETEC.HE) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Headquartered in Finland, the company is primarily listed on the Nasdaq Helsinki exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
BUY5 analysts
3 buy2 hold0 sell
Avg 12m price target11,93

Analyst recommendations

5 analysts · consensus Buy
Buy3
Hold2
Sell0
12-month price target
11,93
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
8,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning DETEC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to DETEC.HE. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Detection Technology Oyj (DETEC.HE) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Headquartered in Finland, the company is primarily listed on the Nasdaq Helsinki exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Detection Technology Oyj maintains a strong liquidity position, with a current ratio of 3.44 and cash and equivalents of EUR 24.98 million, which supports its short-term obligations. The company's debt-to-equity ratio is 0.06, indicating a conservative capital structure with minimal leverage. Free cash flow for the period was EUR 397,130, which is modest but positive, and capital expenditures were negative at EUR -1.60 million, suggesting a reduction in investment in physical assets.

    In terms of profitability, the company reported a return on equity (ROE) of 8.24% and a return on assets (ROA) of 6.19%, both of which are below the industry median for Advanced Medical Equipment & Technology firms. The net income of EUR 6.44 million and operating income of EUR 8.13 million reflect a healthy but not exceptional performance relative to peers.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to regional economic or regulatory risks.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure outlook is neutral, with no major investment plans disclosed. The R&D outlook is also stable, with no material changes expected in the near term.

    The company's risk profile is low, with no immediate liquidity or dilution concerns. The dilution potential is minimal, as the number of shares outstanding has not changed between basic and diluted shares. No recent filings or transcripts indicate material risk events or strategic shifts.

    Recent analyst estimates suggest a generally positive outlook, with a mean price target of EUR 11.93 and a median of EUR 12.00. The mean recommendation score of 1.80 indicates a slight bias toward a "buy" rating, with three strong buy and two hold recommendations.

    Key takeaways
    • Detection Technology Oyj maintains a conservative capital structure with a low debt-to-equity ratio and strong liquidity.
    • The company's profitability metrics are in line with industry norms but not exceptional.
    • Revenue and geographic diversification are limited, which could increase exposure to regional risks.
    • Analysts are cautiously optimistic, with a mean price target of EUR 11.93 and a slight buy bias.
    • No immediate liquidity or dilution risks are present, and the company's risk profile is low.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    €8,66
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    €78.2M
    Net cash
    €20.5M
    Current ratio
    3.4
    Debt / equity
    0.1
    ROA
    6.2%
    ROE
    8.2%
    Cash conversion
    60.0%
    CapEx / revenue
    -1.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,64
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-15 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,64
    Revenueno estimateno estimate110,8M EUR
    Operating incomeno estimateno estimate10,5M EUR
    Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy3
    Buy0
    Hold2
    Sell0
    Strong sell0
    12-month price target€11,93 · Median €12,00
    Low €10,50High €13,20
    Operating income · consensus10,5M EUR
    EPS surprise
    −30,7 %
    reported vs consensus · miss
    Revenue surprise
    −8,8 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low€10,50
    Mean€11,93
    Median€12,00
    High€13,20
    Spot€8,66
    +37.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin8,0 %Above median
    Net Margin6,4 %Above median
    ROE8,2 %Above P75
    Capex / Rev-1,6 %Above median
    D/E0,06Above median
    Cash Conv0,60Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Detection Technology Oyj Market data — financials · 2026-05-27
    • Detection Technology Oyj Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    DETEC.HECanonical
    Nasdaq Helsinki · EUR

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage